As shown in Figures 8(a)–8(b), the antifibrotic effectiveness of THC was further determined by the protein expression of the cardiac fibrotic marker α-SMA, which was dramatically raised in the DCM group and could be significantly inhibited by THC treatment. This evidence concerns the gene ACTA1 and familial dilated cardiomyopathy.